The invention is related to findings that IL-17F-mediated inflammation of airway passages may be mediated via signaling through IL-17R on the basolateral surface of human respiratory epithelial cells. Thus, the present invention provides isolated and purified IL-17F or IL-17R polynucleotides and polypeptides....http://www.google.de/patents/US20060257930?utm_source=gb-gplus-sharePatent US20060257930 - Characterization of IL-17F and IL-17R interactions
